As potential once-a-week insulin advances, AntriaBio eliminates a $44M obligation
November 11, 2014 at 17:22 PM EST
Quietly, AntriaBio Inc. has been working toward a once-a-week injection of basal insulin, the type the pancreas produces at night or to deal with daytime fluctuations...